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 CURRENTOPINION Unravelling atherosclerotic heterogeneity by single
cell RNA sequencing
Ian R. McCrackena, Richard S. Taylorb, Neil C. Hendersonb
Judith C. Sluimera,c, and Andrew H. Bakera,c
The atherosclerotic plaque is a complex environ-
ment containing immune and stromal cells, many
switching phenotype or even transitioning to alter-
native cell types [1–4]. Previous attempts to charac-
terize heterogeneity in atherosclerosis have been
limited by the requirement for predefined cell
surface markers, thus negating new population
discovery [5
&
]. Consequently, cellular heterogeneity
is poorly characterized and likely oversimplified
[6–8].
This challenge in the atherosclerosis field has
recently been addressed by the utility of single cell
RNA sequencing (scRNA-seq), allowing transcrip-
tome analysis at a single cell resolution [9
&&
,10
&&
].
In contrast to previous priori-dependant approaches,
scRNA-seq allows for the unbiased, comprehensive
characterization of cellular identity within a hetero-
geneous population [5
&
]. Importantly, droplet-based
microfluidic platforms permit the sequencing of
thousands of cells in parallel [11].
Two recent studies have utilized a droplet-based
scRNA-seq platform to map leukocyte heterogeneity
in control and fat-fed low-density lipoprotein recep-
tor deficient (Ldlr/) [9
&&
] or apolipoprotein E
(Apoe/) mice [10
&&
], respectively. Unsupervised
clustering revealed more than 10 clusters in each
model, with increased heterogeneity with advanc-
ing disease. Both publications show that the athero-
sclerotic plaques were predominantly composed of
macrophages and T cells. Macrophages were found
to account for a lower proportion of aortic leuko-
cytes in Apoe/mice compared to that observed in
Ldlr/ mice, although the proportion of macro-
phages increased with disease progression in both
models [9
&&
,10
&&
].
Importantly, scRNA-seq identified a new mac-
rophage cluster (identified by enriched expression
of TREM2) and changed pervading views on mac-
rophage biology, as the identified inflammatory
and resident macrophage populations demon-
strated only a weak resemblance to polarized M1
and M2 macrophage phenotypes, again highlight-
ing the limitations of the current classification
system [10
&&
].
Understandably, the authors initially employed
this new technology using homogenous mouse
models, but it will be clearly important to utilize
this technology in human vessels with underlying
atherosclerosis where heterogeneity will be greater
and more difficult to clearly quantify. Owing to
changes in cell phenotype occurring asynchro-
nously, the transcriptional signatures of transition-
ing cells can be used to reconstruct the associated
trajectory [12]. This technology, termed as pseudo-
time analysis, has previously been utilized to iden-
tify potential regulators of myeloid and lymphocyte
differentiation [13,14]. Consequently, application
of pseudotime analysis may be crucial to identifying
putative regulators of important dynamic processes
such as the transdifferentiation of smooth muscle
cells to macrophage-like cells [1,2]. Additionally,
using an in-silico receptor-ligand screen such as that
used by Camp et al. [15] could provide insight into
the level of crosstalk between cell types, thus pro-
viding further insight into the pathogenesis of ath-
erosclerosis. Together, single cell technology and
advanced computational analyses will provide
exciting opportunities to exploit cellular heteroge-
neity in the cardiovascular system, which will aid in
understanding the healthy and disease vessel wall
cellular and molecular dynamics, as well as refining
future therapeutic and diagnostic strategies. How-
ever, complete characterization of atherosclerosis is
likely to require the advent of new technologies
capable of integrating the transcriptional character-
ization of single cells with genomic, epigenetic, and
spatial proteomic data.
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